You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent squamous cell carcinoma of the lip and oral cavity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +26 more
  • Biopsy
  • +5 more
  • Newark, Delaware
  • +52 more
Feb 2, 2023

Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • +4 more
  • Near Infrared Imaging
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 5, 2022

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA

Withdrawn
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
  • +6 more
  • hypofractionated radiation therapy
  • +3 more
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell

Completed
Has Results
  • Stage IV Squamous Cell Carcinoma of the Hypopharynx
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 11, 2021

Oral Cavity Squamous Cell Carcinoma Trial in San Francisco (NisinZ® P, Surgery (non-interventional, standard of care))

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • NisinZ® P
  • Surgery (non-interventional, standard of care)
  • San Francisco, California
    University of California, San Francisco
Oct 18, 2023

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +21 more
  • Atezolizumab
  • +8 more
  • Little Rock, Arkansas
  • +97 more
Jan 27, 2023

Oral Cavity Squamous Cell Carcinoma Trial in Yichang (Sintilimab, Radiotherapy)

Recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • Yichang, Hubei, China
    Department of Medical Oncology, Central Hospital of Yichang City
Feb 18, 2023

Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

Recruiting
  • Squamous Cell Carcinoma of Oral Cavity
  • +3 more
  • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
  • Gliwice, Silesia, Poland
    The Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023

WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA

Recruiting
  • Oral Cancer
  • +2 more
  • Biopsy Specimens Histopathology
  • Rawalpindi, Punjab, Pakistan
    Armed Forces Institute of Pathology
Jun 22, 2023

Oral Squamous Cell Carcinoma, Maxillo-facial Surgery, Biomarkers Trial in Amiens (saliva tube)

Recruiting
  • Oral Squamous Cell Carcinoma
  • +5 more
  • saliva tube
  • Amiens, Picardie, France
    Amiens University Hospital
Mar 17, 2023

Squamous Cell Carcinoma of the Oral Cavity Trial in Rouen (Circulating tumor DNA detection)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • Circulating tumor DNA detection
  • Rouen, France
  • +1 more
Jun 29, 2023

T1 Squamous Cell Carcinomas of the Lip

Active, not recruiting
  • Lip
  • +9 more
    • Nijmegen, Gelderland, Netherlands
    • +2 more
    Nov 2, 2022

    Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

    Active, not recruiting
    Has Results
    • Squamous Cell Carcinoma of the Oropharynx
    • +7 more
    • Tampa, Florida
    • +2 more
    Dec 30, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Hangzhou, Zhejiang, China
      Department of Medical Onocology, First Affiliated Hospital of Zh
    Oct 7, 2023

    Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
    • Black Raspberry
    • (no location specified)
    Oct 16, 2023

    Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

    Recruiting
    • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +28 more
    • San Francisco, California
      University of California, San Francisco
    Dec 16, 2022

    Oral Squamous Cell Carcinoma Trial in Shanghai (Camrelizumab Plus Docetaxel and Cisplatin)

    Recruiting
    • Oral Squamous Cell Carcinoma
    • Camrelizumab Plus Docetaxel and Cisplatin
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Ton
    Nov 9, 2022

    Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous

    Recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • Guangzhou, Guangdong, China
      Liuxiqiang
    Feb 1, 2023

    Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)

    Not yet recruiting
    • Squamous Cell Carcinoma
    • Oral Cavity Squamous Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 27, 2023

    Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous

    Recruiting
    • Recurrent Head and Neck Squamous Cell Carcinoma
    • +5 more
    • Efineptakin alfa
    • San Francisco, California
      University of California San Francisco
    Jul 7, 2022

    Oral Cavity Squamous Cell Carcinoma Trial in Leuven (Durvalumab, Durvalumab + Tremelimumab)

    Active, not recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • Leuven, Belgium
      UZ Leuven
    May 30, 2022